investordatabase.org

Biospring Management, LLC

biospring.com Direct investor

Biospring is a private equity firm that partners with technology-enabled, EBITDA-positive pharma services businesses, focusing on manufacturing and clinical trial services.

Biospring Management, LLC is a private equity firm headquartered in New York, United States. It invests directly in companies, from growth to buyout, in pharma services, biomanufacturing, clinical trial services and digital transformation.

“We partner with technology-enabled, EBITDA-positive pharma services businesses driving innovation in manufacturing and clinical trial services”

Biospring Management, LLC, own website
Layer
Direct investor
Type
Private equity
Stage
GrowthBuyout
Headquarters
New York, United States
Sectors
pharma services, biomanufacturing, clinical trial services, digital transformation

Team, as Biospring Management, LLC publishes it

  • Michelle Detwiler Managing Partner
  • Jennifer Lum Managing Partner
  • Socrates Zacharias Principal
  • Chad Hooper Operating Partner
  • Jordan Feyko Vice President
  • Matt McBryan Associate
  • Jeff Bullock Chief Financial Officer
  • Brian Malone Executive Vice President, Finance
  • Drew Pearson Head of Portfolio Management
  • Billy Breed Director of Business Development
  • Ben Morss Operations Associate
  • Precious Brown Office Manager

Names and roles exactly as listed on biospring.com. Nothing else about these people is recorded.

Co-invests most often with

Derived from portfolio pages both investors publish themselves: each pair below lists at least one company in common. 43 co-investors found.

and 33 more — the graph.

Where this comes from

Every fact above was read from a page Biospring Management, LLC publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.

Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.

Record 3981 · added 2026-09-03 · link last verified 2026-09-06 · confidence medium

Similar investors

Listed under